Dr Agarwal’s Health Care fell nearly 8% on Wednesday, hitting a day’s low of ₹503 on BSE after a ₹2,065 crore block deal by early investors.

About 4.07 crore shares, close to 12.9% of the company’s total equity, changed hands at ₹506.5 each. That works out to a deal size of roughly ₹2,065 crore.

Exchanges have not officially named the buyers or sellers in Wednesday’s trade. This was already mentioned in reports on Tuesday.

Two private equity backers, Hyperion Investments, tied to TPG, and Claymore Investments, a Temasek Holdings vehicle, were said to be trimming an 11% stake between them.

The base deal size was set at ₹1,750 crore, with room to sell another 2% worth ₹250 crore if demand allowed.

The floor price for the sale was fixed at ₹500 a share, a discount of about 7.7% to Tuesday’s closing price of ₹542.75.

As of the June quarter, Hyperion held 23.09% of the company and Claymore held 10.19%, while public and institutional shareholders owned 67.66% and the promoter group held the remaining 32.34%.

The stake sale comes just days after the company talked up its growth plans. CEO Adil Agarwal said the chain is steering more patients towards costlier procedures such as Femto cataract surgery, a shift he said is adding close to 5% to growth on its own.

He said same store sales grew 16.3% in the June quarter, with premium procedures making up about half of that gain and the rest coming from higher patient footfall.

Walk-ins and surgeries across cataract, retina and refractive care also kept rising through the quarter.

The company opened 18 new centres in the June quarter and is targeting more than 40 new ones through FY27, with hiring focused on North and West India as it builds out its network.

Management has said it wants to lift its share among organised eye care players to about 27 to 28% over the next three years.

At 10:00 am, Dr Agarwal’s Health Care was trading around ₹510.50, down 5.94% for the day.

The future of investing is here! Tradz by EquityPandit leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app today and 10x your trading & investing journey!